201 related articles for article (PubMed ID: 36001450)
1. Development and validation of novel RP-HPLC method for midostaurin determination using analytical quality by design approach from regulatory perspective and determination of major degradation compounds of midostaurin using LC-MS.
Reddy Saddala MP; Konduru N; Gundla R; Kowtharapu LP
Biomed Chromatogr; 2022 Dec; 36(12):e5486. PubMed ID: 36001450
[TBL] [Abstract][Full Text] [Related]
2. Favipiravir (SARS-CoV-2) degradation impurities: Identification and route of degradation mechanism in the finished solid dosage form using LC/LC-MS method.
Vemuri DK; Gundla R; Konduru N; Mallavarapu R; Katari NK
Biomed Chromatogr; 2022 Jun; 36(6):e5363. PubMed ID: 35292997
[TBL] [Abstract][Full Text] [Related]
3. A validated stability-indicating reversed-phase-HPLC method for dipyridamole in the presence of degradation products and its process-related impurities in pharmaceutical dosage forms.
Mallavarapu R; Katari NK; Dongala T; Rekulapally VK; Marisetti VM; Vyas G
Biomed Chromatogr; 2022 Jan; 36(1):e5247. PubMed ID: 34541698
[TBL] [Abstract][Full Text] [Related]
4. Stability-indicating HPLC method development and validation of rivaroxaban impurities and identification of forced degradation products using LC-MS/MS.
Cholleti V; Ravindra Kumar Y; Pasula A; Surya PRP
Biomed Chromatogr; 2022 Sep; 36(9):e5424. PubMed ID: 35697473
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
[TBL] [Abstract][Full Text] [Related]
6. Degradation pathways and impurity profiling of the anticancer drug apalutamide by HPLC and LC-MS/MS and separation of impurities using Design of Experiments.
Lakka NS; Kuppan C; Vadagam N; Reddamoni SY; Muthusamy C
Biomed Chromatogr; 2023 Feb; 37(2):e5549. PubMed ID: 36409057
[TBL] [Abstract][Full Text] [Related]
7. Impurity profiling and stability-indicating method development and validation for the estimation of assay and degradation impurities of midostaurin in softgel capsules using HPLC and LC-MS.
Lakka NS; Kuppan C; Ravinathan P
Biomed Chromatogr; 2021 Dec; 35(12):e5222. PubMed ID: 34331472
[TBL] [Abstract][Full Text] [Related]
8. Unique Quality by Design Approach for Developing HPLC and LC-MS Method for Estimation of Process and Degradation Impurities in Pibrentasvir, Antiviral Agent for Hepatitis C.
Vemuri DK; Akshinthala P; Konduru N; Kowtharapu LP; Katari NK; Jonnalagadda SB; Gundla R
ACS Omega; 2022 Dec; 7(51):47650-47661. PubMed ID: 36591161
[TBL] [Abstract][Full Text] [Related]
9. Impurity assessment, development and validation of an RP-HPLC method for the determination of eleven potential impurities of eltrombopag precursor.
Demirhan T; Guksu E; Yazar Y; Keskin E; Bellur Atici E; Özkan SA
J Pharm Biomed Anal; 2024 Jun; 243():116085. PubMed ID: 38471254
[TBL] [Abstract][Full Text] [Related]
10. UPLC and LC-MS studies on degradation behavior of irinotecan hydrochloride and development of a validated stability-indicating ultra-performance liquid chromatographic method for determination of irinotecan hydrochloride and its impurities in pharmaceutical dosage forms.
Kumar N; Sangeetha D; Reddy SP
J Chromatogr Sci; 2012 Oct; 50(9):810-9. PubMed ID: 22661461
[TBL] [Abstract][Full Text] [Related]
11. LC and LC-MS/MS study of forced decomposition behavior of anastrozole and establishment of validated stability-indicating analytical method for impurities estimation in low dose anastrozole tablets.
Reddy YR; Nandan SR; Bharathi DV; Nagaraju B; Reddy SS; Ravindranath LK; Rao VS
J Pharm Biomed Anal; 2009 Oct; 50(3):397-404. PubMed ID: 19541446
[TBL] [Abstract][Full Text] [Related]
12. LC-MS-Compatible Chromatographic Method for Quantification of Potential Organic Impurities of Elagolix Sodium in Tablet Dosage Form with Identification of Major Degradation Products.
Desai P; Prajapati R; Chokshi A
J AOAC Int; 2023 May; 106(3):568-579. PubMed ID: 36721330
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a stability-indicating, single HPLC method for sacubitril-valsartan and their stereoisomers and identification of forced degradation products using LC-MS/MS.
Vijaykumar C; Kumar YR; Aparna P; Rao PSP
Biomed Chromatogr; 2023 Feb; 37(2):e5550. PubMed ID: 36410774
[TBL] [Abstract][Full Text] [Related]
14. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
Lalitha Devi M; Chandrasekhar KB
J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
[TBL] [Abstract][Full Text] [Related]
15. Stability-indicating method development and validation for quantitative estimation of assay and organic impurities of antiviral drug baloxavir marboxil in drug substance and pharmaceutical dosage form using HPLC and LC-MS methods.
Nagulancha BR; Lakka NS; Vandavasi KR
Biomed Chromatogr; 2023 Aug; 37(8):e5644. PubMed ID: 37052118
[TBL] [Abstract][Full Text] [Related]
16. Stability-indicating LC method for the estimation of bendamustine hydrochloride and its related impurities.
Kasa S; Raja Sekhar Reddy M; Kadaboina RS; Murki V; Mulukutla VS
J Chromatogr Sci; 2014 Aug; 52(7):573-83. PubMed ID: 23825351
[TBL] [Abstract][Full Text] [Related]
17. A simple isocratic LC method for quantification of trace-level inorganic degradation impurities (ferricyanide, ferrocyanide, nitrite, and nitrate) in sodium nitroprusside injection and robustness by quality using design approach.
Yenda P; Katari NK; Dongala T; Vyas G; Katakam LNR; Ettaboina SK
Biomed Chromatogr; 2022 Feb; 36(2):e5269. PubMed ID: 34693546
[TBL] [Abstract][Full Text] [Related]
18. Development of stability-indicating UHPLC method for the quantitative determination of silodosin and its related substances.
Shaik JV; Saladi S; Sait SS
J Chromatogr Sci; 2014 Aug; 52(7):646-53. PubMed ID: 23845884
[TBL] [Abstract][Full Text] [Related]
19. A Stability Indicating Method Development and Validation for Separation of Process Related Impurities and Characterization of Unknown Impurities of Tyrosine Kinase Inhibitor Ibrutinib Using QbD Approach by RP-HPLC, NMR Spectroscopy and ESI-MS.
Gopireddy RR; Maruthapillai A; Mahapatra S
J Chromatogr Sci; 2021 Sep; 59(9):830-846. PubMed ID: 33420506
[TBL] [Abstract][Full Text] [Related]
20. A quality-by-design evaluated liquid chromatography method development and validation for the separation and quantification of nitroxoline and its impurities.
Lankalapalli SP; Rachel KV; Chintala V; Kowtharapu LP; Katari NK
J Sep Sci; 2024 Jan; 47(1):e2300760. PubMed ID: 38135885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
